• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国报告人角色自发报告的特征和完整性:使用阿片类药物相关滥用、依赖或戒断的 EudraVigilance 数据库进行的分析。

Characteristics and completeness of spontaneous reports by reporter's role in Germany: An analysis of the EudraVigilance database using the example of opioid-associated abuse, dependence, or withdrawal.

机构信息

Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

University Department of Anesthesiology, Critical Care, Emergency and Pain Medicine, Klinikum Oldenburg, Oldenburg, Germany.

出版信息

Pharmacol Res Perspect. 2023 Apr;11(2):e01077. doi: 10.1002/prp2.1077.

DOI:10.1002/prp2.1077
PMID:36959713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10036728/
Abstract

Spontaneous reporting is based on the experience of all healthcare professionals (HCPs) but also consumers/non-HCPs and therefore reveals a broad picture of a drug's adverse reactions. Recent studies found substantial differences between reports from these varying sources including the reports' completeness. Using the example of opioid-associated abuse, dependence, or withdrawal, this study analyzed the completeness and characteristics of spontaneous reports from Germany focusing on the reporter. Based on EudraVigilance data, we included all cases of abuse, dependence, or withdrawal associated with opioids indicated for pain therapy and filed from Germany until 2018. Completeness and characteristics were analyzed by a reporter (physician, pharmacist, other HCPs, consumers/non-HCPs) and also by time period to account for other influencing factors. In total, 1721 cases were included, mainly filed by physicians (38.5%) and pharmacists (30.7%). Completeness of demographics varied from 74.5% (other HCPs) to 42.7% (consumers/non-HCPs). Consumers/non-HCPs most often provided any indication/comorbidity (75.2%), whereas this was the case for only 20.2% of pharmacists. Large differences between the reporters were found for almost all characteristics. Other HCPs far more often coded a history of drug abuse, dependence, or withdrawal than other reporters (46.9% vs. 11.6%-24.2%, respectively), and fatal outcomes were also mainly filed by other HCPs (68.1% vs. 14.8%-20.4% by all other reporters). Differences in completeness and characteristics were also observed over time. Studies analyzing spontaneous data should consider potential differences between the various reporting groups in terms of completeness and characteristics. Further, the impact of other influencing factors has to be assessed.

摘要

自发报告基于所有医疗保健专业人员(HCPs)的经验,但也包括消费者/非 HCPs,因此揭示了药物不良反应的广泛情况。最近的研究发现,来自这些不同来源的报告之间存在实质性差异,包括报告的完整性。本研究以阿片类药物相关滥用、依赖或戒断为例,分析了德国自发报告的完整性和特征,重点关注报告人。基于 EudraVigilance 数据,我们纳入了所有与疼痛治疗相关的阿片类药物相关滥用、依赖或戒断的病例,并从德国报告至 2018 年。通过报告人(医生、药剂师、其他 HCPs、消费者/非 HCPs)和时间段分析完整性和特征,以考虑其他影响因素。共纳入 1721 例病例,主要由医生(38.5%)和药剂师(30.7%)报告。人口统计学信息的完整性从其他 HCPs 的 74.5%到消费者/非 HCPs 的 42.7%不等。消费者/非 HCPs 最常提供任何适应症/合并症(75.2%),而药剂师只有 20.2%的情况如此。几乎所有特征的报告人之间都存在很大差异。其他 HCPs 比其他报告人更常编码药物滥用、依赖或戒断的病史(46.9%比其他报告人分别为 11.6%-24.2%),并且致命结局也主要由其他 HCPs 报告(68.1%比所有其他报告人分别为 14.8%-20.4%)。随着时间的推移,在完整性和特征方面也观察到不同的差异。分析自发数据的研究应考虑到不同报告人群在完整性和特征方面的潜在差异。此外,还必须评估其他影响因素的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed4/10036728/a35ffe909a8a/PRP2-11-e01077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed4/10036728/a35ffe909a8a/PRP2-11-e01077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fed4/10036728/a35ffe909a8a/PRP2-11-e01077-g001.jpg

相似文献

1
Characteristics and completeness of spontaneous reports by reporter's role in Germany: An analysis of the EudraVigilance database using the example of opioid-associated abuse, dependence, or withdrawal.德国报告人角色自发报告的特征和完整性:使用阿片类药物相关滥用、依赖或戒断的 EudraVigilance 数据库进行的分析。
Pharmacol Res Perspect. 2023 Apr;11(2):e01077. doi: 10.1002/prp2.1077.
2
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.德国医生、药师和消费者上报的药品不良反应报告中信息的比较分析。
Drug Saf. 2023 Dec;46(12):1363-1379. doi: 10.1007/s40264-023-01355-8. Epub 2023 Nov 21.
3
Assessment of factors associated with completeness of spontaneous adverse event reporting in the United States: A comparison between consumer reports and healthcare professional reports.评估与美国自发性不良事件报告完整性相关的因素:消费者报告与医疗保健专业人员报告之间的比较。
J Clin Pharm Ther. 2020 Jun;45(3):462-469. doi: 10.1111/jcpt.13086. Epub 2019 Nov 25.
4
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
5
Patient Reporting in the EU: Analysis of EudraVigilance Data.欧盟的患者报告:EudraVigilance数据的分析。
Drug Saf. 2017 Jul;40(7):629-645. doi: 10.1007/s40264-017-0534-1.
6
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).十年阿片类药物流行的药物警戒信号:用于分析向欧洲药品不良反应数据库(EudraVigilance,EV)和美国食品药品监督管理局不良事件报告系统(FAERS)报告的药物不良反应(ADR)的药物警戒数据集的数据挖掘方法
Pharmaceuticals (Basel). 2022 May 27;15(6):675. doi: 10.3390/ph15060675.
7
Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.语言并非“装在盒子里”:评估欧洲葡萄牙语中药物不良反应自发报告与MedDRA®编码之间的差异。
Res Social Adm Pharm. 2015 Sep-Oct;11(5):664-74. doi: 10.1016/j.sapharm.2014.11.009. Epub 2014 Dec 5.
8
An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.一项观察性研究,旨在比较医疗保健专业人员在CDSCO药品不良反应报告表、黄卡、MedWatch和蓝色表格中提供的信息内容和质量。
Int J Risk Saf Med. 2014;26(1):1-8. doi: 10.3233/JRS-140608.
9
Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.不同报告者自发不良反应报告是否存在差异?图卢兹药物警戒中心的一项研究。
Therapie. 2019 Oct;74(5):521-525. doi: 10.1016/j.therap.2019.01.008. Epub 2019 Mar 31.
10
Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.消费者、制造商和医疗保健专业人员报告的安全问题:对 FDA 数据库中超过 15 年的阿片类药物相关不良反应的详细评估。
Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1627-1635. doi: 10.1002/pds.5105. Epub 2020 Aug 26.

引用本文的文献

1
Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High-Income Countries.消费者、医疗保健专业人员和制药公司自发报告的药品不良反应完整性比较:对两个高收入国家数据库的评估
Pharmacol Res Perspect. 2025 Aug;13(4):e70164. doi: 10.1002/prp2.70164.
2
Evaluating the Efficiency and Productivity of Opioid Substitution Treatment Units in Greece: A DEA-Malmquist Analysis.评估希腊阿片类药物替代治疗单位的效率和生产率:基于数据包络分析-曼奎斯特指数的分析
Healthcare (Basel). 2025 Apr 19;13(8):943. doi: 10.3390/healthcare13080943.
3

本文引用的文献

1
Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.消费者、制造商和医疗保健专业人员报告的安全问题:对 FDA 数据库中超过 15 年的阿片类药物相关不良反应的详细评估。
Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1627-1635. doi: 10.1002/pds.5105. Epub 2020 Aug 26.
2
Assessment of factors associated with completeness of spontaneous adverse event reporting in the United States: A comparison between consumer reports and healthcare professional reports.评估与美国自发性不良事件报告完整性相关的因素:消费者报告与医疗保健专业人员报告之间的比较。
J Clin Pharm Ther. 2020 Jun;45(3):462-469. doi: 10.1111/jcpt.13086. Epub 2019 Nov 25.
3
Metabolic Syndrome as a Risk Factor Among Lebanese Patients with Substance Use Disorder Undergoing Treatment for Recovery Through Rehabilitation or Opioid Substitution Treatment.
代谢综合征作为黎巴嫩物质使用障碍患者通过康复治疗或阿片类药物替代疗法进行康复治疗的风险因素。
Clin Pract. 2024 Dec 10;14(6):2661-2680. doi: 10.3390/clinpract14060210.
4
Evaluating Quality of Life Changes over 12 Months Among Opiate Users from Romania and Associated Worsening Factors.评估罗马尼亚阿片类药物使用者12个月内的生活质量变化及相关恶化因素。
Life (Basel). 2024 Oct 21;14(10):1336. doi: 10.3390/life14101336.
5
Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic Review.与阿片类药物相关的误用、滥用及用药错误不良事件——一项系统评价
Pharmaceuticals (Basel). 2024 Jul 31;17(8):1009. doi: 10.3390/ph17081009.
6
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.德国医生、药师和消费者上报的药品不良反应报告中信息的比较分析。
Drug Saf. 2023 Dec;46(12):1363-1379. doi: 10.1007/s40264-023-01355-8. Epub 2023 Nov 21.
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.2019/20 年药理学简明指南:G 蛋白偶联受体。
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S21-S141. doi: 10.1111/bph.14748.
4
Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.不同报告者自发不良反应报告是否存在差异?图卢兹药物警戒中心的一项研究。
Therapie. 2019 Oct;74(5):521-525. doi: 10.1016/j.therap.2019.01.008. Epub 2019 Mar 31.
5
Frequent Adverse Drug Reactions, and Medication Groups under Suspicion.频繁不良反应及疑似药物类别。
Dtsch Arztebl Int. 2018 Jun 8;115(23):393-400. doi: 10.3238/arztebl.2018.0393.
6
EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection.EudraVigilance 药物安全数据库:用于研究和公共卫生保护的公开可获取数据。
Drug Saf. 2018 Jul;41(7):665-675. doi: 10.1007/s40264-018-0647-1.
7
Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.药物警戒:药剂师对自发上报药品不良反应的看法
Integr Pharm Res Pract. 2017 Mar 22;6:91-98. doi: 10.2147/IPRP.S105881. eCollection 2017.
8
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南:更新和扩展,以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
9
Patient Reporting in the EU: Analysis of EudraVigilance Data.欧盟的患者报告:EudraVigilance数据的分析。
Drug Saf. 2017 Jul;40(7):629-645. doi: 10.1007/s40264-017-0534-1.
10
[Misuse of opioid analgesics. An internet analysis].[阿片类镇痛药的滥用。一项网络分析]
Schmerz. 2014 Oct;28(5):473-82. doi: 10.1007/s00482-014-1466-7.